Nul, a UK-based
healthtech startup developing a supported alcohol reduction platform that
combines clinical care and prescription medication, has raised $1 million in
seed funding. The round was led by dmg ventures and BYVP, with participation
from a group of angel investors.
Alcohol use
disorder and harmful drinking affect millions of people globally, while
treatment options have seen limited innovation in recent decades. Nul aims to
address this gap with medication- and therapy-supported reduction models
designed for individuals who want to reduce their alcohol consumption without
requiring immediate or complete abstinence.
Founded by Matus
Maar, Nul is building a telehealth platform that integrates clinical care,
prescription medication, digital treatment pathways, and behavioural support.
The company’s programme is based on naltrexone, a medication used to reduce
alcohol cravings by targeting reward pathways.
Delivered through a fully remote
subscription service, the programme includes virtual consultations, ongoing
clinical support, and structured digital guidance based on The Sinclair Method.
Commenting on
the company’s mission, Matus Maar, founder and CEO of Nul, said that alcohol
reduction remains one of the largest areas in healthcare that has seen
relatively limited modernisation.
Telehealth and
online pharmacy platforms have transformed categories like weight loss and
mental health, yet alcohol has been left behind despite the scale of the
problem. Nul is about making evidence-based treatment accessible, discreet and
compatible with real life.
Nul launched a
UK test phase in summer 2025 and has onboarded more than 120 paying customers,
reaching an annualised revenue run rate of over £300,000 within its first
months, driven largely by organic demand and word-of-mouth.
The seed funding
will support the company’s full UK commercial launch, expansion of its clinical
and product teams, scaling of customer acquisition, and preparation for future
international expansion, including the US market.
Alongside the seed round, Nul
plans to launch a crowdfunding campaign on Republic Europe,
allowing retail investors to participate in the round and support the company’s
next phase of growth.
